MDR · ASX

MedAdvisor Limited (ASX:MDR)

AU$0.042

 0.001 (2.439%)
ASX:Live
18/09/2025 03:46:10 PM
Near Support Near 52 Week Low HALO Ords HALO Consensus Value GROWTH AUS +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MDR Overview

MDR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About MDR

Website

MedAdvisor Limited

Telephone

61.3.9095.3036

Address

Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124

Description

MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

MDR Price Chart

Key Stats

Market Cap

AU$25.93M

PE

11.90

EV/EBITDA

46.9

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.44

Trade Value (12mth)

AU$28,072.00

1 week

-6.82%

1 month

-30.51%

YTD

-82.17%

1 year

-89.42%

All time high

1.73

Key Fundamentals

EPS 3 yr Growth

109.80%

EBITDA Margin

-17.10%

Operating Cashflow

-$14m

Free Cash Flow Return

-42.70%

ROIC

-188.20%

Interest Coverage

-3.80

Quick Ratio

0.00

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Technology

Next Company Report Date

27-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

MDR Announcements

Latest Announcements

Date Announcements

08 September 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

05 September 25

S&P DJI Announces September 2025 Quarterly Rebalance

×

S&P DJI Announces September 2025 Quarterly Rebalance

03 September 25

Investor Presentation

×

Investor Presentation

03 September 25

Change of registered office

×

Change of registered office

01 September 25

Appendix 3Z - J Xenos

×

Appendix 3Z - J Xenos

29 August 25

Board changes to align with current scale

×

Board changes to align with current scale

29 August 25

Appendix 4E Preliminary Final Report FY25

×

Appendix 4E Preliminary Final Report FY25

29 August 25

FY25 Financial Results

×

FY25 Financial Results

29 August 25

Appendix 3Z - K Hutchinson

×

Appendix 3Z - K Hutchinson

29 August 25

Appendix 3X - Sean Slattery

×

Appendix 3X - Sean Slattery

21 August 25

General Meeting - Results of Meeting

×

General Meeting - Results of Meeting

06 August 25

MedAdvisor Quarterly Activities Report 4Q FY25 - Addendum

×

MedAdvisor Quarterly Activities Report 4Q FY25 - Addendum

31 July 25

MDR 4Q FY25 Quarterly Activity Report and 4C

×

MDR 4Q FY25 Quarterly Activity Report and 4C

31 July 25

MDR 4Q FY25 Investor Presentation

×

MDR 4Q FY25 Investor Presentation

30 July 25

MedAdvisor Investor Webinar Invitation

×

MedAdvisor Investor Webinar Invitation

22 July 25

Notice of Extraordinary General Meeting

×

Notice of Extraordinary General Meeting

18 July 25

Notification regarding unquoted securities - MDR

×

Notification regarding unquoted securities - MDR

17 July 25

Appointment of CFO and Company Secretary

×

Appointment of CFO and Company Secretary

11 July 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

09 July 25

Change in substantial holding

×

Change in substantial holding

07 July 25

Completion of Sale of ANZ Business Operations

×

Completion of Sale of ANZ Business Operations

07 July 25

MedAdvisor Investor Webinar Invitation

×

MedAdvisor Investor Webinar Invitation

02 July 25

Sale of ANZ Business Operations Update

×

Sale of ANZ Business Operations Update

05 June 25

Change in substantial holding

×

Change in substantial holding

20 May 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

19 May 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

MDR Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 0.00 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 0.00 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 54.7 106.7 -6,978.6 Lock Lock Lock
     PE X Lock Lock Lock Lock 55.4 43.0 11.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 15.9 34.9 46.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 0.01 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 74.0 288.5 -258.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -1.2 1.7 0.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.11 0.09 -0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.04 -0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.9 40.8 89.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 545 597 0 Lock Lock Lock
Basic m Lock Lock Lock Lock 545 548 0 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 98 122 63 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.6 24.6 -48.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 20 21 14 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 13 24 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 783.3 87.8 -100.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.8 19.4 -0.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 87 81 100 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 7 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 79.1 391.6 -256.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.4 5.6 -17.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 5 4 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -8 3 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 52.3 134.9 -618.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7.9 2.2 -22.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -11 1 -63 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -11 1 -60 Lock Lock Lock
     Growth % Lock Lock Lock Lock 34.8 107.0 -7,700.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11.5 0.6 -95.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 5 -14 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 2 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -3 -3 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 12 -1 11 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 5 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -197.9 413.7 -380.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.0 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 14 16 10 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 96 99 40 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 12 0 17 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -3 7 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 47 47 41 Lock Lock Lock
Equity $m Lock Lock Lock Lock 48 52 -2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 61 52 16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.0 -15.1 -69.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -11.8 0.8 -151.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -23.3 1.5 3,721.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -14.1 4.3 -34.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -21.9 1.4 -188.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -2.8 9.2 -42.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -1.1 3.6 -3.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 -0.4 -0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -2.3 -5.8 -438.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.8 0.7 1.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.8 0.7 0.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 50.5 47.9 26.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -4.4 11.4 -62.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 9.4 9.2 5.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 3.8 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.3 2.7 6.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.0 1.2 1.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.0 1.2 1.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -10.7 0.8 -100.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -11.0 0.9 -158.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 14.2 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -11.8 0.8 -151.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.0 1.9 -24.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -23.3 1.5 3,721.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -23.3 1.5 3,721.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 38.7 39.7 67.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 38.7 39.7 67.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 21.7 13.8 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 17.0 25.9 67.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.12%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MDR Shortsell

Frequently Asked Questions

The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.042.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.44.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.04.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0.0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 11.90.
The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.042.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.44.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.04.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0.0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 11.90.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.